Paul Anantharajah Tambyah

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Nina Le Bert, Anthony T. Tan, Kamini Kunasegaran et al. · Nature · 2020 · 2.2K citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance

Patrick N. A. Harris, Paul Anantharajah Tambyah, David Chien Lye et al. · JAMA · 2018 · 770 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey

Ann Versporten, Peter Zarb, Isabelle Caniaux et al. · The Lancet Global Health · 2018 · 683 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Catheter-Associated Urinary Tract Infection Is Rarely Symptomatic

Paul Anantharajah Tambyah, Dennis G. Maki · Archives of Internal Medicine · 2000 · 534 citations

Life Sciences, Infectious Diseases, Microbiology +14

Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection

Nina Le Bert, Hannah Clapham, Anthony T. Tan et al. · The Journal of Experimental Medicine · 2021 · 342 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17